# ClinicalTrials.gov record NCT01120236

> PeptideScanner retained ClinicalTrials.gov record NCT01120236 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-02-26, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct01120236-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-02-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01120236-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01120236-leuprolide-v1.json
- Content SHA-256: `101afe9b92f348bdc709c2a22d405bbae44b4524610ca6967154348ddc3e723a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01120236 ([`ctg-observation-nct01120236-2018-02-26-5e1c156754fa`](#source-ctg-observation-nct01120236-2018-02-26-5e1c156754fa))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01120236 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-02-26, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01120236-2018-02-26-5e1c156754fa`](#source-ctg-observation-nct01120236-2018-02-26-5e1c156754fa))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01120236 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-02-26, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01120236-2018-02-26-5e1c156754fa`](#source-ctg-observation-nct01120236-2018-02-26-5e1c156754fa))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01120236-2018-02-26-5e1c156754fa`](#source-ctg-observation-nct01120236-2018-02-26-5e1c156754fa))

## Sources

<a id="source-ctg-observation-nct01120236-2018-02-26-5e1c156754fa"></a>
- **ClinicalTrials.gov record NCT01120236 · retained source version 2018-02-26:5e1c156754faa67ad7ef941711ecbe5eaf92f4900a8259d54125f6d4d9236b96** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01120236) (`ctg-observation-nct01120236-2018-02-26-5e1c156754fa`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01120236." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01120236-leuprolide-v1.json SHA-256: 101afe9b92f348bdc709c2a22d405bbae44b4524610ca6967154348ddc3e723a.